$139.99
Research Studies:
Blend Specification:
Out of stock
FREE Shipping on
orders over $200
ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY. The products offered on this website are intended solely for research and laboratory use. These products are not intended for human or animal consumption. They are not medicines or drugs and have not been evaluated or approved by the FDA to diagnose, treat, cure, or prevent any disease or medical condition. Any form of bodily introduction is strictly prohibited by law.
AOD-9604 + CJC-1295 + Ipamorelin is a research-use-only peptide blend supplied for controlled laboratory workflows, multi-compound documentation review, and analytical characterization. This blend is manufactured under rigorous quality standards to support consistency, traceability, and batch-specific verification for qualified laboratory settings.
AOD-9604 + CJC-1295 + Ipamorelin is intended strictly for laboratory research use only. This product is not intended for human or animal consumption, therapeutic use, diagnostic use, clinical use, veterinary use, or as a food, drug, cosmetic, dietary supplement, or household product.
| CAS No. | 170851-70-4 |
|---|---|
| Purity | ≥99% |
| Sequence | Aib-His-D-2Nal-D-Phe-Lys-NH2 |
| Molecular Formula | C38H49N9O5 |
| Molecular Weight | 711.85 g/mol |
| Synthesis | Solid-phase synthesis |
| Format | Lyophilized powder |
| Solubility | Soluble in water or 1% acetic acid |
| Stability & Storage | Stable for up to 24 months at -20°C. After reconstitution, may be stored at 4°C for up to 4 weeks or at -20°C for up to 6 months. |
| Applications | Growth hormone release studies, muscle growth research, body composition improvement |
| Appearance | White lyophilized powder |
| Shipping Conditions | Shipped at ambient temperature; once received, store at -20°C |
| Regulatory/Compliance | Manufactured in a facility that adheres to cGMP guidelines |
| Safety Information | Refer to provided MSDS |
Consider these supplementary peptides for a comprehensive research approach.
Researchers searching for buy AOD+CJC+Ipamorelin Blend online should evaluate AOD+CJC+Ipamorelin Blend as a research-use-only laboratory material, not a consumer product. For laboratory buyers, the key considerations are compound identity, purity documentation, batch-specific COAs, lot traceability, product labeling, and storage information. This guide explains how to evaluate AOD+CJC+Ipamorelin Blend for controlled research procurement through Pure Lab Peptides.
Researchers can buy AOD+CJC+Ipamorelin Blend online for laboratory research by reviewing RUO labeling, batch-specific COA documentation, purity data, identity information, storage guidance, and supplier transparency before selecting a source. Products discussed in this article are intended for laboratory research use only and are not intended for human or animal consumption.
The phrase “buy AOD+CJC+Ipamorelin Blend online” is addressed here as laboratory research procurement intent, not personal-use intent. In this context, the keyword reflects how qualified researchers, laboratory buyers, and technical procurement teams compare RUO sourcing options, not how a consumer would evaluate a wellness product.
Research procurement review should focus on whether the material is labeled for research use only, whether batch-specific documentation is available, whether the stated identity and purity are supported by analytical methods, and whether the product record can be matched to a lot number. U.S. labeling rules for certain laboratory-phase products use the phrase “For Research Use Only. Not for use in diagnostic procedures,” and FDA guidance discusses when RUO and IUO labeling is appropriate for IVD products under development. [1] [2]
AOD+CJC+Ipamorelin Blend is best evaluated as a multi-component peptide blend for research procurement. The individual components are commonly identified in scientific databases and literature as peptide materials with distinct molecular records. PubChem indexes AOD-9604, CJC-1295, and Ipamorelin as separate chemical entries, which supports component-level identity review during documentation assessment. [3] [4] [5]
Published analytical literature describes AOD9604 as a peptide material examined through detection and in vitro metabolism methods, while CJC-1295 appears in literature on modified growth-hormone-releasing factor analogs and Ipamorelin appears in literature as a pentapeptide investigated in ghrelin receptor-related research. [6] [7] [8]
For RUO procurement, those literature contexts should be used only to understand compound identity, class, receptor or pathway terminology, and analytical documentation needs. They should not be translated into product-use claims. GHRH receptor and ghrelin receptor database records provide neutral pathway context for CJC-1295 and Ipamorelin-related research, but receptor relevance is not use guidance for an RUO material. [9] [10]
Blend composition should be evaluated through documentation and identity review, not expected outcomes or use protocols.
Researchers search this phrase because online procurement pages often determine whether a laboratory can evaluate RUO availability, product form, batch documentation, identity testing, purity information, and supplier transparency before purchase approval. A technical buyer may search buy AOD+CJC+Ipamorelin Blend to compare RUO labeling, COA access, lot traceability, and documented product form across suppliers.
The phrase does not imply consumer use. A compliant procurement review asks whether the material is clearly labeled for research use only, whether the AOD+CJC+Ipamorelin Blend COA is batch-specific, whether AOD+CJC+Ipamorelin Blend purity documentation aligns with the product page, and whether AOD+CJC+Ipamorelin Blend identity testing is supported by appropriate analytical methods.
Researchers planning to buy AOD+CJC+Ipamorelin Blend online for laboratory research should treat quality review as a documentation exercise. The most useful supplier signals are clear RUO positioning, batch-specific COA access, component-level identity support, lot traceability, storage information, and restrained scientific language.
| Evaluation Area | What Researchers Should Review | Why It Matters for RUO Procurement |
| RUO labeling | Confirm the product is clearly labeled for research use only | Helps separate research procurement from human-use positioning |
| COA availability | Review the batch-specific certificate of analysis | Supports lot-level documentation and quality review |
| Purity data | Look for analytical support for the stated purity | Helps evaluate material consistency |
| Identity testing | Review the listed HPLC, LC-MS, mass spectrometry, or related identity method | Helps confirm the material matches the listed blend components |
| Lot traceability | Match lot numbers across product and documentation | Supports research recordkeeping |
| Product form | Confirm whether the material is supplied as lyophilized powder or another documented form | Supports laboratory planning |
| Storage information | Review storage and handling documentation | Helps maintain material integrity in laboratory settings |
| Supplier language | Confirm the supplier avoids therapeutic or personal-use claims | Supports research-use-only positioning |
A batch-specific COA should be reviewed as a complete documentation package. Researchers should check the product name, lot number, test date, purity percentage, analytical method, component identity information, molecular weight or sequence fields when included, product form, and storage documentation. General analytical guidance emphasizes that validation and method suitability matter when interpreting identity, purity, and related measurements. [11]
A purity percentage alone does not establish complete compound identity; researchers should evaluate purity, identity, method, lot number, and documentation together. Laboratory competence frameworks such as ISO/IEC 17025 focus on valid results and trusted testing processes, while NIST reference-material resources illustrate the importance of documented values, certificates, and traceability in measurement contexts. [12] [13]
For peptide materials, HPLC is widely used for peptide analysis and purification, and mass spectrometry is well suited to synthetic peptide identity and purity assessment. LC-MS workflows are also discussed in peptide impurity characterization literature. [14] [15] [16]
For a blend, the review should also ask whether component naming is consistent across the product page, label, and COA. Peptide impurity work shows why structurally related peptide impurities and closely related peptide identities can require careful analytical review rather than reliance on a single headline purity value. [17] [18] [19]
Published literature on the AOD, CJC-1295, and Ipamorelin components is mixed across database records, analytical detection work, receptor or pathway research, preclinical models, and limited human-study settings. That landscape is useful for scientific context, but it is not a basis for product-use claims about an RUO material.
CJC-1295 has been examined in published studies as a long-acting GHRH analog, including human study settings, animal-model work, and serum-protein profiling. Published clinical literature should not be interpreted as use guidance for RUO materials. [20] [21] [22]
Ipamorelin appears in published literature related to ghrelin receptor and secretagogue research. Some studies are receptor-focused, some are preclinical, and some are outside the scope of research-material procurement. [23] [24] [25]
Structural research on the ghrelin receptor has examined peptide recognition and receptor activation mechanisms using cryo-EM models, which provides pathway context for receptor-related research without establishing any use claim for a supplier’s RUO material. [26]
| Research Area | What Literature Examines | Evidence Type | RUO Interpretation |
| Compound identity | Molecular structure, formula, peptide classification, and component records | Database / analytical | Supports identification, not product-use claims |
| Pathway or category context | GHRH receptor, ghrelin receptor, peptide-fragment, and model-specific research areas | Review / in vitro / preclinical / limited clinical | Useful for research context, not therapeutic claims |
| Analytical testing | Purity, identity, related impurities, and batch verification | HPLC / LC-MS / mass spectrometry / COA | Supports documentation review |
| Storage and stability | Material form and handling considerations | Laboratory documentation | Supports research workflow planning |
| Research-Safe Statement | Why It Is Acceptable | Non-Compliant Version to Avoid |
| “AOD+CJC+Ipamorelin Blend is discussed through component-level peptide and receptor-pathway research context.” | Describes literature context without making a product claim | “AOD+CJC+Ipamorelin Blend helps with a human outcome.” |
| “Researchers should review COA and identity data before procurement.” | Focuses on documentation and quality review | “Users should buy AOD+CJC+Ipamorelin Blend for results.” |
| “Pure Lab Peptides supplies AOD+CJC+Ipamorelin Blend as a research-use-only material.” | Clarifies intended use | “Pure Lab Peptides supplies AOD+CJC+Ipamorelin Blend for therapy.” |
| “The phrase buy AOD+CJC+Ipamorelin Blend online is addressed as research procurement intent.” | Qualifies commercial search intent | “Buy AOD+CJC+Ipamorelin Blend online for personal use.” |
| “Blend composition should be evaluated through documentation and identity review.” | Keeps the focus on procurement records | “Blend components create enhanced results.” |
Pure Lab Peptides presents AOD+CJC+Ipamorelin Blend as a research-use-only material. The product is supplied as lyophilized powder with a stated ≥99% purity claim, and a batch-specific COA is available for documentation review. Laboratory buyers should review the product page, purity information, RUO labeling, storage and handling information, and lot-level documentation before procurement.
Review the Pure Lab Peptides AOD+CJC+Ipamorelin Blend research-use-only product page for RUO labeling, product details, purity information, and batch-specific documentation. Researchers comparing suppliers may also review the research peptide collection, the Pure Lab Peptides blogs, and shipping and returns information for procurement planning.
Buy AOD+CJC+Ipamorelin Blend online should not be interpreted as personal-use guidance on this page. The phrase is addressed as laboratory procurement intent for qualified researchers reviewing RUO labeling, documentation, purity data, identity information, and supplier transparency.
Published research can help define component terminology, analytical context, and research categories. It does not establish instructions or outcomes for an RUO material. Literature about component pathways should remain scientific background, not a product claim.
A stated purity percentage is one quality signal, but it is not a complete identity package. Researchers should review the AOD+CJC+Ipamorelin Blend COA, component naming, lot number, analytical method, and identity documentation together.
For research procurement, batch-specific documentation matters because it ties the product label, lot number, and analytical record to the specific material received. Generic documentation does not provide the same level of lot-level traceability.
Supplier language should never replace analytical review. A compliant RUO purchasing process prioritizes AOD+CJC+Ipamorelin Blend supplier documentation, component identity testing, lot traceability, product form, storage information, and COA review.
Researchers can buy AOD+CJC+Ipamorelin Blend online for laboratory research from an RUO supplier that provides clear labeling, batch-specific COA access, purity information, identity documentation, storage guidance, and lot-level traceability. Pure Lab Peptides provides a product page for AOD+CJC+Ipamorelin Blend research procurement review.
Before buying AOD+CJC+Ipamorelin Blend online, researchers should check RUO labeling, the batch-specific COA, stated purity, component naming, analytical method, lot number consistency, product form, storage documentation, and supplier language. The supplier should position the material strictly for laboratory research, not human or animal consumption.
A COA matters when buying AOD+CJC+Ipamorelin Blend because it connects the material to batch-level quality documentation. Researchers should review the COA for product name, lot number, purity data, identity method, test date, and consistency with the label and product page.
AOD+CJC+Ipamorelin Blend is not intended for human or animal consumption. On this page, the product is discussed only as a research-use-only laboratory material. Procurement review should focus on labeling, COA documentation, purity information, identity testing, storage information, and supplier transparency.
Research use only means AOD+CJC+Ipamorelin Blend is positioned as a laboratory research material rather than a consumer, clinical, veterinary, or diagnostic product. Researchers should evaluate the product through documentation, analytical support, lot-level traceability, and controlled laboratory recordkeeping.
Published literature about AOD, CJC-1295, Ipamorelin, or related receptor pathways should be interpreted as scientific context only. It can help researchers understand terminology and analytical considerations, but it should not be converted into product-use guidance, expected outcomes, or procurement claims for RUO materials.
Qualified researchers evaluating AOD+CJC+Ipamorelin Blend should review product labeling, COA status, identity documentation, purity information, storage guidance, and supplier transparency. Review the AOD+CJC+Ipamorelin Blend product page for RUO labeling, purity information, and available batch-specific documentation.
Our team is ready to assist you with any inquiries regarding our catalogue of peptides and their applications.
Discount Applied Successfully!
Your savings have been added to the cart.
There are no reviews yet.